In a complex, uncertain and increasingly fragmented decision making landscape getting traction for positive policy development requires new approaches including effective cross industry alliances to get cut through.

To ensure that a strong and aligned viewpoint of US life science companies was heard at a time of Brexit, NHS funding changes and local service re-organisation we worked with the American Pharmaceutical Group (APG) to deliver the inaugural US life sciences summit in the U.K.

The summit brought together global leaders across key disciplines of research, medical and commercial with senior Government representatives to discuss opportunities for the U.K. to become a global life science leader.

The event was a decisive landmark helping to inform the publication of this key Life Science Strategy report to Government which included new funding for research and strategic goals to improve NHS and industry collaboration.